- Movahedi Motlagh, F.; Soleimanpour, H. R.; Shamsara, M.; Modarressi, M. H.*
CRISPR/Cas9 ablated BCL11A unveils genes with possible roles in globin switching.
Journal of Advanced Pharmaceutical Bulletin, 2023. (Q1, IF: 3.7) - Movahedi Motlagh, F.; Soleimanpour, H. R.; Emami, A.; Kadkhoda, S.; Rasti, A.; Modarressi, M. H.*
BCL11A and correlated key genes ascribable to globin switching: An in silico study.
Journal of Cardiovascular & Hematological Disorders – Drug Targets, 2022. - Etemadzadeh, A.; Salehipour, P.; Movahedi Motlagh, F.; Khalifeh, M.; Asadbeigi, A.; Tabrizi, M.; Shirkouhi, R.; Modarressi, M. H.
An optimized CRISPR/Cas12a assay to facilitate detection of the BRAF V600E mutation.
Journal of Clinical Laboratory Analysis, 2024. (Q1, IF: 2.6) - Cheraghi, S.; Mobaderi, T.; Mottaghi, A.; Movahedi Motlagh, F.; Taghizadeh, S.; Eghbali, M.
Genetic variants in the MC4R gene and the risk of obesity/overweight: A systematic review and meta-analysis.
Diabetes, Obesity and Metabolism, 2025. - Movahedi Motlagh, F.; Kadkhoda, S.; Motamedrad, M.; Javidzadeh, P.; Khalilian, S.; Modarressi, M. H.; Ghafouri-Fard, S.
Roles of non-coding RNAs in cell death pathways involved in resistance and recurrence of cancer.
Pathology – Research and Practice, 2023. (Q1, IF: 3.3) - Rasti, A.; Abazari, O.; Dayati, P.; Kardan, Z.; Salari, A.; Khalili, M.; Movahedi Motlagh, F.; Modarressi, M. H.*
Identification of potential key genes linked to gender differences in bladder cancer based on GEO datasets.
Journal of Molecular Diversity, 2023. (IF: 3.36) - Movahedi-Motlagh, F.*; Salavaty, A.; Barabadi, M.; Cheshomi, H.; Dehghan Esmatabadi, M. J.; Shahmoradi, M.; Soleimanpour-Lichaei, H. R.*
Potential role of RAB6C-AS1 long non-coding RNA in different cancers.
Journal of Cellular Physiology, 2018. (Q1, IF: 5.5) - Movahedi Motlagh, F.; Gholami, O.
Comparison of umbelliprenin and auraptene in cytotoxic effects and MCL-1 gene expression.
Indian Journal of Pharmaceutical Sciences, 2017. (ISI, IF: 0.76) - Movahedi Motlagh, F.; Rajaei, B.; Massumi, M.; Kabir Salmani, M.; Soleimanpour-Lichaei, H. R.
Optimized lentiviral transduction procedure for human induced pluripotent stem cell generation.
Journal of Biomedicine, 2015. - Dehghan Esmatabadi, M. J.; Bakhshinejad, B.; Movahedi Motlagh, F.; Babashah, S.; Sadeghizadeh, M.
Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumor relapse.
Journal of Biosciences, 2016. (ISI, IF: 2.79) - Saebnia, N.; Sadeghizadeh, M.; Dehghan Esmatabadi, M. J.; Movahedi Motlagh, F.
Main factors involved in colorectal cancer recurrence and therapeutic approaches.
Journal of Police Medicine, 2016. - Dehghan Esmatabadi, M.; Movahedi Motlagh, F.; Etemadzadeh, A.; Hajigholami, S.
The most well-known cancer stem cell markers and their roles in tumor growth, drug resistance, and metastasis.
Journal of Human Genetics and Genomics, 2018; 2(1): e65253.
Conference Presentations (Continued Numbering)
- Movahedi Motlagh, F.; Rasti, A.; Soleimanpour-Lichaei, H. R.; Modarressi, M. H.
Cloning of gRNAs designed for editing the BCL11A erythroid enhancer into PX458 and PX459 plasmids.
8th National & 2nd International Webinar on Medical Genetics: Diagnostics & Research, Mashhad, Iran, March 2022. - Rasti, A.; Movahedi Motlagh, F.; Sabbagh Nejad Yazd, S.; Modarressi, M. H.*
Evaluation of urinary gene expression panel for non-invasive screening of bladder cancer.
8th National & 2nd International Webinar on Medical Genetics, Mashhad, Iran, March 2022. - Gholami, O.; Movahedi-Motlagh, F.
Comparative cytotoxic effects of umbelliprenin and auraptene on cancer cell lines.
1st International & 22nd Iranian Congress of Physiology and Pharmacology, Kashan, Iran, September 2015. - Movahedi, F.; Rajaei, B.; Soleimanpour, H. R.
Different methods of generating induced pluripotent stem cells with respect to clinical applications.
Stem Cells & Regenerative Medicine International Congress, Mashhad, Iran, 2015. - Movahedi, F.; Rajaei, B.; Massumi, M.; Kabir Salmani, M.; Soleimanpour, H. R.
Optimization of lentiviral transduction for generation of human iPS cells.
7th International Congress of Laboratory and Clinic, Tehran, Iran, 2015. - Movahedi, F.; Soleimanpour, H. R.
Comparison of induced pluripotent stem cells with embryonic stem cells.
7th International Congress of Laboratory and Clinic, Tehran, Iran, 2015. - Movahedi, F.; Rajaei, B.; Soleimanpour, H. R.*; Massumi, M.; Kabir Salmani, M.
Generation and characterization of human induced pluripotent stem cells derived from a diabetic patient using a non-integrating polycistronic lentiviral system.
Royan International Twin Congress, Tehran, Iran, 2014. - Rajaei, B.; Massumi, M.; Sanati, M. H.; Shamsara, M.; Movahedi, F.
Efficient programming of human induced pluripotent stem cells into definitive endoderm-like cells.
Royan International Twin Congress, Tehran, Iran, 2014. - Movahedi, F.; Rajaei, B.; Soleimanpour, H. R.; Kabir Salmani, M.; Massumi, M.*
Generation of pluripotent stem cells from adult human fibroblasts with type 1 diabetes.
Biotechnology Congress, Tehran, Iran, 2013. (Oral Presentation)
|
